glp-1 side effects blindness GI Adverse of Glucagon-Like Peptide-1 Receptor Agonists GLP-1 Drugs Like Ozempic Face

10.1016/j.jacbts.2018.09.004 28

Emerging Therapies and Expanding Potential The research agenda just outlined assumes a relatively stable therapeutic landscape, one in which the primary task is generating better evidence for the combinations already in use

Impact of insulin and insulin resistance on brain dopamine signalling and reward processingAn underexplored mechanism in the pathophysiology of depression

Among many other medicinal plants, Terminalia arjuna is a natural DPP-IV inhibitor with significant cardio-protective effects owing to the presence of some active ingredients, including arjungenin, ellagic acid, and arjunic acid

Identify any potential deficiencies or changes that may arise